Common press release of the Helmholtz Centre for Infection Research and the Saarland University
A draft of the new HIPS building, which will unite drug researchers under one roof.
Architekten BDA RDS PARTNER
Infection research meets pharmacy: At the HIPS approximately 150 scientists are committed to the search for new drugs. The ground-breaking ceremony on Wednesday, 21 August, marks the beginning of the construction of a new research building. Media representatives are invited to attend the greetings at 10:00 and the breaking ground at approximately 11:00. There will be the possibility for press photos and background discussion.
Prof. Johanna Wanka, the German Federal Minister of Education and Research, and Annegret Kramp-Karrenbauer, the State Prime Minister of Saarland, will attend the ground-breaking ceremony. Also Prof. Jürgen Mlynek, President of the Helmholtz Association, is expected to be present.
Many antibiotics, once celebrated as miracle drugs against infectious diseases, have long lost their potency to the unrelenting rise in antibiotic resistance. As a result, new drugs are desperately needed.
In order to close a gap in drug research, the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, and the Saarland University founded the HIPS in 2009. Almost exactly four years later, the symbolic ground-breaking ceremony on 21 August will be the starting signal for construction of a new HIPS building to begin. On about 4,500 square metres of effective area, three departments and an additional three junior research groups will find new space on the campus of the Saarland University. "So far, our labs are distributed all over the campus," says Prof. Rolf Müller, Managing Director of the HIPS. "In 2015, the new building will be completed, and all staff can then be accommodated under one roof. It will even offer space for new research groups."
The cost, which totals 25 million euros, is funded for a substantial part by the German State of Saarland as well as the European Regional Development Fund. The European Union contribution is aimed at promoting competitiveness in this region. The HIPS’ own share of the cost is 10 %.
“Infection research is the HZI’s focus, whereas traditionally the Saarland University has been strong in pharmaceutical research,” says Prof. Dirk Heinz, the HZI’s scientific director. “The combination with HIPS areas of competence is unprecedented in Germany.” The HIPS is Germany’s first publicly funded non-university-affiliated research institute exclusively dedicated to pharmaceutical research. Scientists are screening natural substances for their therapeutic potential. "Bacteria, fungi and plants produce many highly active metabolites, including antibacterials," explains Müller. When researchers discover an interesting substance, they optimize it for pharmaceutical application using different methods. In addition, HIPS scientists are conducting research into how drugs ultimately arrive at their intended target in the body. To enable drugs to cross biological barriers, they develop drug transporters.
“Saarland University is among the best universities in Germany when it comes to pharmaceutical research. With the new building, novel interesting perspectives will open up for junior researchers,” says Saarland University’s President Prof. Volker Linneweber.
Media representatives are invited to attend the ceremony on the construction site in Stuhlsatzenhausweg. Parking is possible in the car park at Stuhlsatzenhausweg – Entrance Uni Ost. For additional questions, please contact the HZI Public Relations Department at (+49) 531-6181-1401 or by email at: firstname.lastname@example.org.The Helmholtz Centre for Infection Research (HZI)
http://www.helmholtz-hzi.deThe Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)
Dr. Birgit Manno | Helmholtz-Zentrum
Pollinator friendliness can extend beyond early spring
22.11.2019 | American Society for Horticultural Science
Wound healing in mucous tissues could ward off AIDS
22.11.2019 | University of Washington Health Sciences/UW Medicine
Conventional light microscopes cannot distinguish structures when they are separated by a distance smaller than, roughly, the wavelength of light. Superresolution microscopy, developed since the 1980s, lifts this limitation, using fluorescent moieties. Scientists at the Max Planck Institute for Polymer Research have now discovered that graphene nano-molecules can be used to improve this microscopy technique. These graphene nano-molecules offer a number of substantial advantages over the materials previously used, making superresolution microscopy even more versatile.
Microscopy is an important investigation method, in physics, biology, medicine, and many other sciences. However, it has one disadvantage: its resolution is...
Nanooptical traps are a promising building block for quantum technologies. Austrian and German scientists have now removed an important obstacle to their practical use. They were able to show that a special form of mechanical vibration heats trapped particles in a very short time and knocks them out of the trap.
By controlling individual atoms, quantum properties can be investigated and made usable for technological applications. For about ten years, physicists have...
An international team of scientists, including three researchers from New Jersey Institute of Technology (NJIT), has shed new light on one of the central mysteries of solar physics: how energy from the Sun is transferred to the star's upper atmosphere, heating it to 1 million degrees Fahrenheit and higher in some regions, temperatures that are vastly hotter than the Sun's surface.
With new images from NJIT's Big Bear Solar Observatory (BBSO), the researchers have revealed in groundbreaking, granular detail what appears to be a likely...
The Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM in Dresden has succeeded in using Selective Electron Beam Melting (SEBM) to...
15.11.2019 | Event News
15.11.2019 | Event News
05.11.2019 | Event News
22.11.2019 | Materials Sciences
22.11.2019 | Life Sciences
22.11.2019 | Life Sciences